The global head and neck cancer market is driven by increase in the patient population, rise in health care infrastructure in developing economies, growth of the pharmaceutical industry, surge in research and development activity, increase in product approvals, and rise in government initiatives. An estimated 75% of head ... Read more
The segmentation of the head and neck cancer market is conducted on the basis of the type of head and neck cancer, diagnosis, region, treatment type, and end-user. Based on the type of head and neck cancer, the market is segmented into laryngeal cancer, salivary gland cancer, pharyngeal cancer, nasopharyngeal cancer, lip and oral cavity cancer, and others. By diagnosis, the market for hand and neck cancer is segmented into blood tests, bioscopy screening tests, ... Read more
Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. Furthermore, head and neck cancers initiate in squamous cells, cells that line moist surfaces such as those inside the head and neck (for example, the mouth, nose, and throat). ... Read more
The Head and Neck Cancer Market is estimated to be valued at US$ 1,851.2 Mn in 2022 and is expected to exhibit a CAGR of 7.3% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Head and Neck Cancer Market refers to the market for diagnostic and therapeutic solutions aimed at treating head and neck cancers. These cancers commonly affect the nasal cavity, sinuses, lips, ... Read more
